Data / Form D filings / ME THERAPEUTICS HOLDINGS INC.
ME THERAPEUTICS HOLDINGS INC.: Form D filing
ME THERAPEUTICS HOLDINGS INC., a biotechnology company in Vancouver, British Columbia, Canada, filed a Form D with the SEC in 2023. The latest, on August 29, 2023, reports $3,350 sold of a $3,350 offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 177 ROBSON STREET, Vancouver, British Columbia, Canada, V6B 0
- Phone
- (236) 516-7714
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- British Columbia, Canada
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1990555
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 29, 2023 | New notice | $3,350 | $3,350 | 2 | Aug 9, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jamil Kassam | Executive Officer | |
| John Priatel | Director | |
| Quinn Martin | Executive Officer | |
| Salim Dhanji | Executive Officer, Director | |
| Kenneth Harder | Director | |
| Karim Nanji | Director |
Every Form D from the week of Aug 28, 2023 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what ME THERAPEUTICS HOLDINGS INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.